Stocks to watch: These small-cap stocks will be in focus on Monday!
Stocks to watch: These small-cap stocks will be in focus on Monday!

Stocks to watch: These small-cap stocks will be in focus on Monday!

The following small-cap stocks are likely to be in focus on Monday, January 02, 2023:

Kaustubh Bhosale Article rating: 4.2

Due to early losses in the European markets, the benchmark BSE Sensex and NSE Nifty retraced all intra-day gains to close the last trading day of the year on a negative note.

Overnight Digest: Stocks likely to be in focus on April 27
Overnight Digest: Stocks likely to be in focus on April 27

Overnight Digest: Stocks likely to be in focus on April 27

India VIX plunged beyond 9 per cent to end the trading session at 19.19

Shreya Chaware Article rating: 3.0

Taking favourable cues from the other Asian markets, the domestic equity markets gained momentum and traded substantially in green, breaking the losing streak of the previous two trading sessions. The oil market, still driving a roller coaster ride with the prices, moved up and down sharply.  

Stocks to watch: These small-cap stocks will be in focus on Monday!
Stocks to watch: These small-cap stocks will be in focus on Monday!

Stocks to watch: These small-cap stocks will be in focus on Monday!

Hariom Pipe Industries, Dynacons Systems & Solutions, Nahar Industrial Enterprises, Krishana Phoschem, Anand Rathi Wealth, JTL Infra, Hardwyn India, VIP Clothing, Jash Engineering, and Royal Orchid Hotels made a fresh 52-week high today.

Armaan Madhani Article rating: 4.4

BSE Small-cap index outperformed broader markets, closing the session with gains of 0.27 per cent.

Stocks to watch: These smallcap stocks will be in focus tomorrow!
Stocks to watch: These smallcap stocks will be in focus tomorrow!

Stocks to watch: These smallcap stocks will be in focus tomorrow!

Dwarikesh Sugar Industries, InfoBeans Technologies, The Ugar Sugar Works, Mangalam Global Enterprise, SEL Manufacturing, Arihant Capital Markets, Zydus Lifesciences, Lemon Tree Hotels and Mawana Sugars made a fresh 52-week high today.  

Armaan Madhani Article rating: 3.9

On Wednesday, Indian equity markets staged a healthy recovery from lower levels. 

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList